Author: Web Desk

Explore all our news . .

Recent Posts

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan to initiate dosing of Phase 1/2 in Q4 2024 to evaluate REC-1245 in a biomarker enriched patient population, including patients with solid tumors and lymphoma

Islamabad Sets Strategic Goals for CPEC Ahead of SCO Summit

Islamabad: In a strategic move to bolster economic ties with China, the Pakistani government conducted a high-level review of China-Pakistan Economic Corridor (CPEC) projects on October 2, 2024. The meeting, chaired by Minister for Planning, Developme…